Related Experiment Videos
Lessons learned from young-onset diabetes in China.
Juliana C N Chan1, Maggie C Y Ng
1Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, Hong Kong, China. jchan@cuhk.edu.hk
Current Diabetes Reports
|May 6, 2003
Summary
The rising prevalence of young-onset diabetes in China presents diagnostic and therapeutic challenges. Early identification and tailored management are crucial for these heterogeneous cases.
Area of Science:
- Endocrinology and Metabolism
- Genetics and Molecular Biology
- Public Health
Background:
- Young-onset diabetes (YOD) prevalence is increasing in China.
- YOD is etiologically and phenotypically diverse, complicating diagnosis and treatment.
- A significant portion of YOD patients experience insulin secretory failure due to autoimmune, monogenic, or unidentified causes.
Purpose of the Study:
- To highlight the diagnostic and therapeutic challenges posed by the rising prevalence of YOD in China.
- To emphasize the need for a multidisciplinary and holistic approach in managing YOD.
- To underscore the potential of understanding the molecular basis of YOD for improved clinical outcomes.
Main Methods:
- Review of current literature on YOD in China.
- Analysis of etiological and phenotypic heterogeneity in YOD.
- Discussion of diagnostic and management strategies for YOD.
Main Results:
- YOD exhibits significant heterogeneity, with 30-50% presenting insulin secretory failure.
- Other YOD cases show a family history and metabolic syndrome features.
- Current management requires specialized, integrated care approaches.
Conclusions:
- Effective management of YOD necessitates early identification and tailored interventions.
- A deeper understanding of the molecular underpinnings of YOD is essential for advancing diagnosis, classification, and treatment.
- Multidisciplinary collaboration is key to addressing the complexities of YOD.